Amgen Inc. (AMGN)
Amgen Highlights MariTide, IMDELLTRA Pipeline Progress and Growth Priorities
Amgen NASDAQ: AMGN outlined its growth priorities, late-stage pipeline progress and capital-allocation framework during a Morgan Stanley conference, as newly appointed Chief Financial Officer Thomas Dittrich emphasized execution, financial discipline and cash-on-cash returns.
Amgen Inc. (AMGN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Amgen Inc. (AMGN) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Here's Why Amgen (AMGN) is a Strong Value Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Here is What to Know Beyond Why Amgen Inc. (AMGN) is a Trending Stock
Zacks.com users have recently been watching Amgen (AMGN) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
4 Healthcare Stocks to Play Safe as Fed Gears Up for Rate Hike
AMGN, BHC, CDNA and CNC offer defensive healthcare plays as inflation climbs and the Fed readies for a possible rate hike.
Amgen Highlights 26% Growth Drivers, IMDELLTRA Momentum and MariTide Potential
Amgen NASDAQ: AMGN executives highlighted growth across its key commercial products, progress in late-stage development programs and a continued focus on profitability and cash returns during a Wells Fargo biotech and pharma discussion.
Amgen Drops 10% on a Trial It Didn't Even Run
Amgen TodayAMGNAmgen$379.72 -2.75 (-0.72%) As of 12:05 PM Eastern This is a fair market value price provided by Massive. Learn more.52-Week Range$269.77▼$447.03Dividend Yield2.65%P/E Ratio23.61Price Target$381.68Add to WatchlistAmgen Inc. NASDAQ: AMGN delivered a strong earnings report on Aug. 4.
Are Medical Stocks Lagging Amgen (AMGN) This Year?
Here is how Amgen (AMGN) and Charles River Laboratories (CRL) have performed compared to their sector so far this year.
Amgen (AMGN) Dips More Than Broader Market: What You Should Know
The latest trading day saw Amgen (AMGN) settling at $382.47, representing a -2.25% change from its previous close.
AMGN, AZN Drug Combo Shows Survival Benefit in Lung Cancer Study
Amgen and AstraZeneca's Imdelltra-Imfinzi combo shows survival benefits in first-line ES-SCLC, potentially broadening both drugs' reach.
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
A failed cholesterol trial from Novartis (NYSE:NVS | NVS Price Prediction) is dragging the Lp(a) drug class lower and hitting Amgen (NASDAQ:AMGN) harder than any large-cap peer in Tuesday trading.
Take the Zacks Approach to Beat the Markets: Oportun Financial, Uranium Royalty & Amgen in Focus
Zacks spotlights Oportun Financial, Uranium Royalty and Amgen, alongside standout gains from its key stock portfolios.
